|
10-02-2012, 01:34 PM
|
#1
|
Senior Member
Join Date: Mar 2006
Posts: 4,778
|
3000 person study-- her2+ early breast cancer divided into two groups by HR status
HR= hormone receptor
I think this study oversimplifies things. The good news is that ER+her2+ prognosis may be even better than previously believed.
I think ER+her2+ bc will be found to have important subgroup distinctions, but that is just my take on it
Breast Cancer Recurrence Defined by Hormone Receptor Status
Human epidermal growth factor (HER2) positive breast cancers are often treated with the same therapy regardless of hormone receptor status. New research published in the journal Breast Cancer Research shows that women whose HER2 positive cancer was also hormone (estrogen and progesterone) receptor (HR) negative had an increased risk of early death, and that their cancer was less likely to recur in bone than those whose cancer retained hormone sensitivity.
Breast cancer is a heterogeneous disease with many different subtypes. HR positive cancer is more likely to be luminal A or B type and be treated with endocrine therapy including tamoxifen or aromatase inhibitors, while HR negative cancer is more likely to be basal or 'HER2-enriched'. HER2 positive cancers can fall into both of these categories.
A multicenter study from 13 National Comprehensive Cancer Network (NCCN) hospitals analyzed data from over 3000 women diagnosed with early stage HER2 positive breast cancer. At first recurrence, most of the women in the study were treated with chemotherapy and/or with anti-HER2 therapy.
Dr. Ines Vaz-Luis, who led the study revealed, "In this large group of patients with HER2 positive breast cancer, we found significant associations between presence of HR and presenting features, patterns of recurrence and survival outcomes. In the first five years after treatment more women died from HR negative cancer than HR positive."
Recurrence in the brain or bone was also linked to receptor status, with more HR negative cancer in the brain and HR positive cancer in bone. About half of recurrent tumors tested had switched progesterone or estrogen receptor status (positive to negative or vice versa) or lost HER2 status during the study.
Vaz-Luis, continued, "Based on our findings, HR status defines two different subsets of HER2 positive cancers. To combat this, we believe that studies which look at new drugs for treating HER2-positive breast cancer should also integrate hormone receptor status into their design."
SOURCE:
Breast Cancer Research, October 1, 2012
|
|
|
10-02-2012, 02:15 PM
|
#2
|
Senior Member
Join Date: Aug 2006
Posts: 3,380
|
Re: 3000 person study-- her2+ early breast cancer divided into two groups by HR statu
I think the study showed that triple positive bc behaves more like HR+/Her2- bc, with later relapses and mets to the bone instead of visceral organs. The paper also said this:
"Concordant with previous knowledge, trastuzumab increases the rates of survival independently of HR status. After stratifying by adjuvant trastuzumab use, the differences in survival by HR status persisted. It is worth noting that despite a lower rate of pathologic complete responses (pCR) among patients with HR+/HER2+ tumors across neoadjuvant trials [10, 39-45], the overall prognosis of such patients is not worse than those with HR-/HER2+ tumors. These findings also suggest that in patients with HR+/HER2+ tumors, lack of pCR will, potentially, have less prognostic value than among patients with HR-/HER2+ tumors [46]."
Hopeful
|
|
|
10-02-2012, 02:35 PM
|
#3
|
Senior Member
Join Date: Jan 2007
Location: Thornhill, Ontario
Canada
Posts: 2,320
|
Re: 3000 person study-- her2+ early breast cancer divided into two groups by HR statu
Thanks for keeping on top of this Lani.
I'm sure those of us who are HR+ as well as HER2+ are grateful to the research being done on our small subsect of BC.
And I keep reminding myself that WE are the statistics... my onc. told me in Dec. 2006, just after my mastectomy and before I began chemo in January 2007, that I would be the future of HER2+ statistics as they had only been giving Herceptin to early stagers for about a year in Canada...
Going on six years now, no recurrence for me!!
all the best
caya
__________________
ER90%+/PR 50%+/HER 2+
1.7 cm and 1.0 cm.
Stage 1, grade 2, Node Negative (16 nodes tested)
MRM Dec.18/06
3 x FEC, 3 x Taxotere
Herceptin - every 3 weeks for a year, finished May 8/08
Tamoxifen - 2 1/2 years
Femara - Jan. 1, 2010 - July 18, 2012
BRCA1/BRCA2 Negative
Dignosed 10/16/06, age 48 , premenopausal
Mild lymphedema diagnosed June 2009 - breast surgeon and lymph. therapist think it's completely reversible - hope so.
Reclast infusion January 2012
Oopherectomy October 2013
15 Years NED!!
|
|
|
10-02-2012, 04:24 PM
|
#4
|
Senior Member
Join Date: Nov 2005
Location: Ireland
Posts: 3,463
|
Re: 3000 person study-- her2+ early breast cancer divided into two groups by HR statu
Thanks Lani, highly triple pos here and still waiting for the hammer to fall!!!!
__________________
Tricia
Dx July '05 IDC 1.9cm Triple positive 3/9 nodes positive
A/C X 4 ..Taxol/Herceptin x 12 wks then herceptin 1 yr
Rads x 36 ..oophorectomy August '06
Currently taking Arimidex..
June 2011 osteopenia/ zometa x1 yearly- stopped Zometa 2015 as Dexa show normal bone density.
Stopped Arimidex July 2014- Restarted Arimidex 2015 for a further two years on the advice of my Onc.
2014 Normal Dexa scan
2018 Mammo all clear, still NED!
|
|
|
10-02-2012, 04:44 PM
|
#5
|
Senior Member
Join Date: May 2008
Location: Hershey, PA. Live The Sweet Life!
Posts: 2,005
|
Re: 3000 person study-- her2+ early breast cancer divided into two groups by HR statu
Tricia,
That hammer is NOT going to fall for you! Thanks Lani and Hopeful for the "hope!"
__________________
Smile On!
Laurel
Dx'd w/multifocal DCIS/IDS 3/08
7mm invasive component
Partial mast. 5/08
Stage 1b, ER 80%, PR 90%, HER-2 6.9 on FISH
0/5 nodes
4 AC, 4 TH finished 9/08
Herceptin every 3 weeks. Finished 7/09
Tamoxifen 10/08. Switched to Femara 8/09
Bilat SPM w/reconstruction 10/08
Clinical Trial w/Clondronate 12/08
Stopped Clondronate--too hard on my gizzard!
Switched back to Tamoxifen due to tendon pain from Femara
15 Years NED
I think I just might hang around awhile....
|
|
|
10-03-2012, 06:52 AM
|
#6
|
Senior Member
Join Date: Feb 2007
Location: Paris, France
Posts: 858
|
Re: 3000 person study-- her2+ early breast cancer divided into two groups by HR statu
Well, I am not the good example...and unfortunately on this forum I am not the only one. But this is not statistics. I believe like you Lani that it is more complicated than that. BUT Tricia, MOST of our HER2 sisters don't have metastasis! No hammer for you! Michka
__________________
08.2006 3 cm IDC Stage 2-3, HER2 3+ ER+90% PR 20%
FEC, Taxol+ Herceptin, Mastectomy, Radiation, Herceptin 1 year followed by Tykerb 1 year,Aromasin /Faslodex
12.2010 Mets to liver,Herceptin+Tykerb
03.2011 Liver resection ER+70% PR-
04.2011 Herceptin+Navelbine+750mg Tykerb
06.2011 Liver ned, Met to sternum. Added Zometa 09.2011 Cyberknife for sternum
11.2011 Pet clear. Stop Navelbine, continuing on Hercpetin+Tykerb+Aromasin
02.2012 Mets to lungs, nodes, liver
04.2012 TDM1, Ned in 07.2012
04.2015 Stop TDM1/Kadcyla, still Ned, liver problems
04.2016 Liver mets. Back on Kadcyla
08.2016 Kadcyla stopped working. mets to liver lungs bones
09.2016 Biopsy to liver. no more HER2, still ER+
09.2016 CMF Afinitor/Aromasin/ Xgeva.Met to eye muscle Cyberknife
01.2017 Gemzar/Carboplatin/ Ibrance/Faslodex then Taxotere
02.2017 30 micro mets to brain breathing getting worse and worse
04.2017 Liquid biopsy/CTC indicates HER2 again. Start Herceptin with Halaven
06.2017 all tumors shrunk 60% . more micro mets to brain (1mm mets) no symptoms
|
|
|
10-03-2012, 07:14 AM
|
#7
|
Senior Member
Join Date: Feb 2009
Posts: 1,526
|
Re: 3000 person study-- her2+ early breast cancer divided into two groups by HR statu
Agree Lani that as time goes by we will find more subgroups for all including her2+/ ER-. My onc TOTALLY agrees with you, we discuss it each visit!
Ellie
|
|
|
Posting Rules
|
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is Off
|
|
|
All times are GMT -7. The time now is 06:17 PM.
|